GRPR and cancer: The expression of gastrin releasing peptide receptors (GRPRs) in a series of human tumors has provided the rationale for the application of anti-GRPR peptide radioligands in cancer diagnosis and therapy following a patient-tailored theranostic approach [1,2,3].